» Articles » PMID: 23946590

Is Diabetes Mellitus a Risk Factor for Pancreatic Cancer?

Overview
Specialty Gastroenterology
Date 2013 Aug 16
PMID 23946590
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between diabetes mellitus and the risk of pancreatic cancer has been a matter of study for a long period of time. The importance of this topic is due to two main causes: the possible use of recent onset diabetes as a marker of the disease and, in particular, as a specific marker of pancreatic cancer, and the selection of a population at risk for pancreatic cancer. Thus, we decided to make an in-depth study of this topic; thus, we carried out an extensive literature search in order to re-assess the current knowledge on this topic. Even if diabetes is found a decade before the appearance of pancreatic cancer as reported in meta-analytic studies, we cannot select those patients already having non detectable pancreatic cancer, at least with the imaging and biological techniques available today. We believe that more studies are necessary in order to definitively identify diabetes mellitus as a risk factor for pancreatic cancer taking into consideration that approximately 10 years are needed to diagnose symptomatic pancreatic cancer. At present, the answer to the as to whether diabetes and pancreatic cancer comes first similar to the adage of the chicken and the egg is that diabetes is the egg.

Citing Articles

Surgical management of pancreatic cancer in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a 5 years retrospective descriptive study.

Dinagde T, Abubeker Z BMC Surg. 2024; 24(1):223.

PMID: 39103810 PMC: 11302827. DOI: 10.1186/s12893-024-02503-2.


VNN1 overexpression in pancreatic cancer cells inhibits paraneoplastic islet function by increasing oxidative stress and inducing β‑cell dedifferentiation.

Qin W, Kang M, Li C, Zheng W, Guo Q Oncol Rep. 2023; 49(6).

PMID: 37114564 PMC: 10173380. DOI: 10.3892/or.2023.8557.


Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth.

Velazquez-Torres G, Fuentes-Mattei E, Choi H, Yeung S, Meng X, Lee M Gastroenterol Rep (Oxf). 2020; 8(4):261-276.

PMID: 32843973 PMC: 7434590. DOI: 10.1093/gastro/goaa018.


Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.

Rawla P, Sunkara T, Gaduputi V World J Oncol. 2019; 10(1):10-27.

PMID: 30834048 PMC: 6396775. DOI: 10.14740/wjon1166.


Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer.

Slotwinski R, Slotwinska S Cent Eur J Immunol. 2017; 41(4):392-403.

PMID: 28450803 PMC: 5382885. DOI: 10.5114/ceji.2016.65139.


References
1.
Hjalgrim H, Frisch M, Ekbom A, Kyvik K, Melbye M, Green A . Cancer and diabetes--a follow-up study of two population-based cohorts of diabetic patients. J Intern Med. 1997; 241(6):471-5. DOI: 10.1111/j.1365-2796.1997.tb00004.x. View

2.
Egawa N, Tu Y, Sanaka M, Kamisawa T . Family history of diabetes and pancreatic cancer. Pancreas. 2005; 30(1):15-9. View

3.
Magruder J, Elahi D, Andersen D . Diabetes and pancreatic cancer: chicken or egg?. Pancreas. 2011; 40(3):339-51. DOI: 10.1097/MPA.0b013e318209e05d. View

4.
Andren-Sandberg A, Ihse I . Factors influencing survival after total pancreatectomy in patients with pancreatic cancer. Ann Surg. 1983; 198(5):605-10. PMC: 1353132. DOI: 10.1097/00000658-198311000-00008. View

5.
Noy A, Bilezikian J . Clinical review 63: Diabetes and pancreatic cancer: clues to the early diagnosis of pancreatic malignancy. J Clin Endocrinol Metab. 1994; 79(5):1223-31. DOI: 10.1210/jcem.79.5.7962312. View